8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
5.51%
Positive growth while 3141.T shows revenue decline. John Neff would investigate competitive advantages.
7.49%
Cost increase while 3141.T reduces costs. John Neff would investigate competitive disadvantage.
-2.33%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-7.43%
Margin decline while 3141.T shows 1.08% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.00%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-1.33%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
6.07%
Total costs growth while 3141.T reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
-5.91%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-4.92%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-9.89%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-5.57%
Both companies show declining income. Martin Whitman would check industry conditions.
-10.51%
Both companies show margin pressure. Martin Whitman would check industry conditions.
2.64%
Other expenses growth less than half of 3141.T's 99.90%. David Dodd would verify if advantage is sustainable.
-4.93%
Pre-tax income decline while 3141.T shows 33.22% growth. Joel Greenblatt would examine position.
-9.90%
Pre-tax margin decline while 3141.T shows 40.45% growth. Joel Greenblatt would examine position.
-4.57%
Tax expense reduction while 3141.T shows 133.39% growth. Joel Greenblatt would examine advantage.
-5.25%
Net income decline while 3141.T shows 2.70% growth. Joel Greenblatt would examine position.
-10.20%
Net margin decline while 3141.T shows 8.27% growth. Joel Greenblatt would examine position.
-5.25%
EPS decline while 3141.T shows 2.71% growth. Joel Greenblatt would examine position.
-5.25%
Diluted EPS decline while 3141.T shows 2.71% growth. Joel Greenblatt would examine position.
-0.00%
Share count reduction while 3141.T shows 1.39% change. Joel Greenblatt would examine strategy.
-0.00%
Diluted share reduction while 3141.T shows 0.00% change. Joel Greenblatt would examine strategy.